Maynard Um
-
-
-
-
-
-
-
Organon launches two denosumab biosimilars in Canada
-
-
-
-
-
-
-
Piper Sandler Upgrades Organon & Co. (OGN) to Neutral, raises PT
-
-
-
-
-
-
-
Organon audit committee finds no improper conduct in biosimilar purchases
-
-
-
-
-
-
-
Increasing unusual option volume: ELAN AMKR ASST BYND HPP CHGG UMC OGN CYBN ALLT
-
-
-
-
-
-
-
OGN DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action -
-
-
-
-
-
-
-
OGN DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN
-
-
-
-
-
-
-
BFA Law Notifies ORGANON & CO. (OGN) Investors with Losses to Contact the Firm by July 22 Class Action Deadline to Potentially Recover Losses
-
459,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

